KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Lam Research (LRCX) over the last 17 years, with Q3 2025 value amounting to $6.7 billion.

  • Lam Research's Cash & Equivalents rose 1031.03% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 1031.03%. This contributed to the annual value of $6.4 billion for FY2025, which is 928.21% up from last year.
  • Lam Research's Cash & Equivalents amounted to $6.7 billion in Q3 2025, which was up 1031.03% from $6.4 billion recorded in Q2 2025.
  • Lam Research's Cash & Equivalents' 5-year high stood at $6.7 billion during Q3 2025, with a 5-year trough of $3.5 billion in Q2 2022.
  • Over the past 5 years, Lam Research's median Cash & Equivalents value was $5.3 billion (recorded in 2023), while the average stood at $5.1 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 2028.54% in 2022, then skyrocketed by 5153.48% in 2023.
  • Over the past 5 years, Lam Research's Cash & Equivalents (Quarter) stood at $5.1 billion in 2021, then dropped by 11.83% to $4.5 billion in 2022, then rose by 25.39% to $5.6 billion in 2023, then increased by 0.75% to $5.7 billion in 2024, then rose by 18.14% to $6.7 billion in 2025.
  • Its Cash & Equivalents stands at $6.7 billion for Q3 2025, versus $6.4 billion for Q2 2025 and $5.5 billion for Q1 2025.